By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Opko Health, Inc. Licensee Tesaro, Inc. (TSRO) Submits New Drug Application for Rolapitant 9/8/2014 12:28:41 PM
Tesaro, Inc. (TSRO) Announces Submission Of Rolapitant New Drug Application (NDA) To FDA 9/8/2014 7:02:28 AM
Tesaro, Inc. (TSRO) Announces Participation At Several Upcoming Investor Conferences 8/21/2014 8:09:17 AM
Paradigm Announces Molecular Profiling Collaboration With Tesaro, Inc. (TSRO) 8/20/2014 8:13:00 AM
Tesaro, Inc. (TSRO) Announces Second-Quarter 2014 Operating Results 7/25/2014 7:32:09 AM
Tesaro, Inc. (TSRO) Appoints Mary Lynne Hedley, Ph.D., As Chief Operating Officer 7/25/2014 7:30:40 AM
Tesaro, Inc. (TSRO) To Announce Second-Quarter 2014 Financial Results On July 24, 2014 7/11/2014 6:00:37 AM
Tesaro, Inc. (TSRO) Summarizes Phase 3 Rolapitant Data Presented At The 2014 American Society of Clinical Oncology Annual Meeting And Provides An Update On Niraparib Development Strategy 6/2/2014 9:51:47 AM
Tesaro, Inc. (TSRO) Appoints Tim Pearson As Chief Financial Officer 5/28/2014 9:01:46 AM
Tesaro, Inc. (TSRO) Announces Webcast Of Investor & Analyst Briefing at American Society of Clinical Oncology 5/27/2014 9:29:15 AM